Evolving management of NSCLC – FlorezLab

FlorezLab shared on X:

“The treatment landscape of advanced NSCLC is evolving! Join Dr. Narjust Florez for an informative discussing the evolving management of NSCLC, focusing on Antibody-Drug Conjugates (ADCs). For more details, visit.”

Source: FlorezLab/X

Narjust Florez is the Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.

In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.